Cabio Biotech (Wuhan) Co., Ltd. (SHA:688089)
19.77
+0.23 (1.18%)
Mar 10, 2026, 2:04 PM CST
-20.67% (1Y)
| Market Cap | 3.26B |
| Revenue (ttm) | 574.88M |
| Net Income (ttm) | 156.70M |
| Shares Out | 166.80M |
| EPS (ttm) | 0.94 |
| PE Ratio | 20.79 |
| Forward PE | 14.26 |
| Dividend | 0.20 (1.03%) |
| Ex-Dividend Date | Jul 10, 2025 |
| Volume | 2,110,283 |
| Average Volume | 2,262,210 |
| Open | 19.58 |
| Previous Close | 19.54 |
| Day's Range | 19.50 - 19.85 |
| 52-Week Range | 18.36 - 31.13 |
| Beta | 0.51 |
| RSI | 48.56 |
| Earnings Date | Apr 23, 2026 |